Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

Insider Trades & Whales

Insider trades are parsed from SEC Form 4 filings (first-party). The ownership breakdown below is computed first-hand from SEC 13F-HR + Form 4 (institutions from 13F, insiders from Form 4). For the full filer list and quarter-over-quarter position changes, see the Institutional (13F) tab.

Ownership Breakdown

Insiders 12.56%Institutions 32.98%48 filers

Top Institutions

Form 4 Transactions

50 most recent
DateInsiderTitleCodeSharesPriceValue
May 14, 2026Jermasek DouglasEVP, Corporate StrategyA169,500$0.0000$0.00
May 14, 2026Townsend JohnCFOA169,500$0.0000$0.00
May 14, 2026Gupta PramodEVP, Pharmaceuticals and BDA169,500$0.0000$0.00
May 14, 2026Laumas SandeepDirectorA42,100$0.0000$0.00
May 14, 2026Laumas SandeepDirectorA84,200$0.0000$0.00
May 14, 2026Kenkare-Mitra SaraDirectorA42,100$0.0000$0.00
May 14, 2026Kenkare-Mitra SaraDirectorA84,200$0.0000$0.00
May 14, 2026Gupta Shalabh K.CEOA762,200$0.0000$0.00
May 14, 2026Laumas SandeepDirectorA42,100$0.0000$0.00
May 14, 2026Laumas SandeepDirectorA84,200$0.0000$0.00
May 14, 2026Townsend JohnCFOA169,500$0.0000$0.00
May 14, 2026Jermasek DouglasEVP, Corporate StrategyA169,500$0.0000$0.00
May 14, 2026Gupta PramodEVP, Pharmaceuticals and BDA169,500$0.0000$0.00
May 14, 2026Kenkare-Mitra SaraDirectorA42,100$0.0000$0.00
May 14, 2026Kenkare-Mitra SaraDirectorA84,200$0.0000$0.00
May 14, 2026Gupta Shalabh K.CEOA762,200$0.0000$0.00
Aug 25, 2025Aggarwal GauravDirectorD3,199$1000.0000$3.20M
Aug 25, 2025Aggarwal GauravDirectorC652,900––
Jul 28, 2025Jermasek DouglasEVP of Corporate StrategyA10,000$0.0000$0.00
Jul 28, 2025Gupta PramodEVP, Pharmaceuticals and BDA90,000$0.0000$0.00
Jul 28, 2025Townsend JohnChief Financial OfficerA10,000$0.0000$0.00
Jul 28, 2025Laumas SandeepDirectorA21,200$0.0000$0.00
Jul 28, 2025Gupta Shalabh K.CEOA325,000$0.0000$0.00
Jul 28, 2025Kenkare-Mitra SaraDirectorA21,200$0.0000$0.00
Jul 28, 2025Aggarwal GauravDirectorA21,200$0.0000$0.00
Feb 18, 2025Aggarwal GauravDirectorD1,400,000$1000.0000$1.40B
Feb 18, 2025Aggarwal GauravDirectorC1,400,000––
Oct 9, 2024Aggarwal GauravDirectorD5,500,000$1000.0000$5.50B
Oct 9, 2024Aggarwal GauravDirectorC5,500,000––
Aug 12, 2024Jermasek DouglasEVP of Corporate StrategyA81,750$0.0000$0.00
Aug 12, 2024Gupta Shalabh K.CEOA232,868$0.0000$0.00
Aug 12, 2024Townsend JohnChief Financial OfficerA40,256$0.0000$0.00
Aug 12, 2024Gupta PramodEVP, Pharmaceuticals and BDA81,750$0.0000$0.00
Apr 15, 2024Gupta Shalabh K.CEOA1,319,583$0.0000$0.00
Apr 15, 2024Gupta PramodEVP, Pharmaceuticals and BDA463,250$0.0000$0.00
Apr 15, 2024Jermasek DouglasEVP of Corporate StrategyA463,250$0.0000$0.00
Apr 15, 2024Townsend JohnChief Financial OfficerA228,119$0.0000$0.00
Sep 5, 2023Aggarwal GauravDirectorA180,000$0.0000$0.00
Sep 5, 2023Ryan John LDirectorA112,147$0.0000$0.00
Sep 5, 2023Kenkare-Mitra SaraDirectorA180,000$0.0000$0.00
Sep 5, 2023Laumas SandeepDirectorA189,236$0.0000$0.00
Aug 28, 2023Townsend JohnChief Financial OfficerA570,329$0.0000$0.00
Aug 28, 2023Jermasek DouglasEVP of Corporate StrategyA1,355,000$0.0000$0.00
Aug 28, 2023Gupta Shalabh K.CEOA4,684,775$0.0000$0.00
Aug 28, 2023Gupta PramodEVP, Pharmaceuticals and BDA1,355,000$0.0000$0.00
Jul 11, 2023Aggarwal GauravDirectorC18,621,655$0.0000$0.00
Jul 11, 2023Aggarwal GauravDirectorC11,638,534$0.0000$0.00
Jul 11, 2023Aggarwal GauravDirectorC12,802,388$0.0000$0.00
Jul 11, 2023Aggarwal GauravDirectorC13,429,000$0.0000$0.00
Jul 11, 2023Aggarwal GauravDirectorC59,961,729$1000.0000$59.96B